Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04142437

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi…

In this observational study researcher want to learn more about the effectiveness of drug VITRAKVI (generic name: larotrectinib) and how well the drug is tolera…

United States150 participantsStarted 2020-04-03

Treatment: larotrectinib(Vitrakvi, BAY2757556)

All recent trials (5 shown)

Active — Not RecruitingPhase 2

NCT02568267

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C),…

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2…

United States534 participantsStarted 2015-11-19

Treatment: Entrectinib

CompletedNot Applicable

NCT05236257

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connec…

This is an observational study in which data from the past of children and young people with a specific cancer, called NTRK gene fusion positive infantile fibro…

France93 participantsStarted 2022-03-10

Treatment: Larotrectinib (Vitrakvi, BAY2757556), Standard of Care

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi…

All recent trials (5 shown)

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C),…

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connec…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi…

All recent trials (5 shown)

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C),…

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connec…

Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects

Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects